Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 1
1999 2
2000 2
2001 1
2002 7
2003 4
2004 5
2005 6
2006 6
2007 3
2008 5
2009 14
2010 6
2011 12
2012 16
2013 17
2014 11
2015 11
2016 21
2017 19
2018 9
2019 14
2020 16
2021 21
2022 15
2023 21
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
The future of immunotherapy for sarcoma.
Tsukahara T, Emori M, Murata K, Mizushima E, Shibayama Y, Kubo T, Kanaseki T, Hirohashi Y, Yamashita T, Sato N, Torigoe T. Tsukahara T, et al. Among authors: hirohashi y. Expert Opin Biol Ther. 2016 Aug;16(8):1049-57. doi: 10.1080/14712598.2016.1188075. Epub 2016 May 27. Expert Opin Biol Ther. 2016. PMID: 27158940 Review.
Peptide vaccination therapy: Towards the next generation.
Tsukahara T, Hirohashi Y, Kanaseki T, Nakatsugawa M, Kubo T, Sato N, Torigoe T. Tsukahara T, et al. Among authors: hirohashi y. Pathol Int. 2016 Oct;66(10):547-553. doi: 10.1111/pin.12438. Epub 2016 Jul 19. Pathol Int. 2016. PMID: 27435148 Review.
YTHDC2 Promotes Malignant Phenotypes of Breast Cancer Cells.
Tanabe A, Nakayama T, Kashiyanagi J, Yamaga H, Hirohashi Y, Torigoe T, Satomi F, Shima H, Maeda H, Kutomi G, Takemasa I, Sahara H. Tanabe A, et al. Among authors: hirohashi y. J Oncol. 2022 Oct 7;2022:9188920. doi: 10.1155/2022/9188920. eCollection 2022. J Oncol. 2022. PMID: 36245989 Free PMC article. Review.
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore.
Willis J, Anders RA, Torigoe T, Hirohashi Y, Bifulco C, Zlobec I, Mlecnik B, Demaria S, Choi WT, Dundr P, Tatangelo F, Di Mauro A, Baldin P, Bindea G, Marliot F, Haicheur N, Fredriksen T, Kirilovsky A, Buttard B, Vasaturo A, Lafontaine L, Maby P, El Sissy C, Hijazi A, Majdi A, Lagorce C, Berger A, Van den Eynde M, Pagès F, Lugli A, Galon J. Willis J, et al. Among authors: hirohashi y. Cancers (Basel). 2023 Aug 10;15(16):4045. doi: 10.3390/cancers15164045. Cancers (Basel). 2023. PMID: 37627073 Free PMC article.
Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma.
Yamada S, Miyata H, Isono M, Hori K, Yanagawa J, Murai A, Minowa T, Mizue Y, Sasaki K, Murata K, Tokita S, Nakatsugawa M, Iwabuchi S, Hashimoto S, Kubo T, Kanaseki T, Tsukahara T, Abe T, Shinohara N, Hirohashi Y, Torigoe T. Yamada S, et al. Among authors: hirohashi y. Cancer Immunol Immunother. 2023 Jul;72(7):2057-2065. doi: 10.1007/s00262-023-03388-5. Epub 2023 Feb 16. Cancer Immunol Immunother. 2023. PMID: 36795123
ACLP Activates Cancer-Associated Fibroblasts and Inhibits CD8+ T-Cell Infiltration in Oral Squamous Cell Carcinoma.
Sekiguchi S, Yorozu A, Okazaki F, Niinuma T, Takasawa A, Yamamoto E, Kitajima H, Kubo T, Hatanaka Y, Nishiyama K, Ogi K, Dehari H, Kondo A, Kurose M, Obata K, Kakiuchi A, Kai M, Hirohashi Y, Torigoe T, Kojima T, Osanai M, Takano K, Miyazaki A, Suzuki H. Sekiguchi S, et al. Among authors: hirohashi y. Cancers (Basel). 2023 Aug 28;15(17):4303. doi: 10.3390/cancers15174303. Cancers (Basel). 2023. PMID: 37686580 Free PMC article.
[Dendritic cell and cancer immune checkpoint].
Kubo T, Hirohashi Y, Torigoe T. Kubo T, et al. Among authors: hirohashi y. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(5):468-472. doi: 10.2177/jsci.39.468. Nihon Rinsho Meneki Gakkai Kaishi. 2016. PMID: 27795504 Free article. Review. Japanese.
240 results